Amoxicillin NDC 42708-112

NDC codes

FDA NDC Directory

Product NDC (as listed)42708-112Labeler and product segments. Claims need a package NDC.

Product NDC at billing width42708-0112Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
42708-112-20	42708011220	20 TABLET, FILM COATED in 1 BOTTLE (42708-112-20)Marketed from Apr 17, 2018 · Sample package

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Amoxicillin
Generic name (nonproprietary): amoxicillin
Active ingredients: Amoxicillin — 875 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: QPharma, Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 065056
Marketing start: Sep 26, 2000
Listing expires: Dec 31, 2026
Other FDA classes: Penicillins (Chemical structure)
Identifiers: Product ID 42708-112_4682c86c-a853-ade0-e063-6394a90acbceSPL ID 4682c86c-a853-ade0-e063-6394a90acbceSPL set ID 7f40b439-d826-4a19-b184-702e9bd5a883RxCUI 308194UNII 804826J2HU
Pharmacologic class: Penicillin-class Antibacterial

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N442708011220 followed by a unit qualifier and the quantity

Package 42708-0112-20. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 19, 2025.

Indications (excerpt from the label)

Adults and Pediatric Patients Upper Respiratory Tract Infections of the Ear, Nose, and Throat: Amoxicillin tablets, amoxicillin for oral suspension, amoxicillin tablets (chewable), and amoxicillin capsules are indicated in the treatment of infections due to susceptible (ONLY β-lactamase-negative) isolates of Streptococcus species. (α- and β-hemolytic isolates only), Streptococcus pneumoniae , Staphylococcus spp., or Haemophilus influenzae . Infections of the Genitourinary Tract: Amoxicillin tablets, amoxicillin for oral suspension, amoxicillin tablets (chewable), and amoxicillin capsules are indicated in the treatment of infections due to susceptible (ONLY β-lactamase-negative) isolates of E…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 065056

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 065056
Product	Strength	Form · route	Labeler	Product NDC
Amoxicillin	Amoxicillin 500 mg/1	Tablet, Film coatedOral	Teva Pharmaceuticals USA, Inc.	0093-2263
Amoxicillin	Amoxicillin 875 mg/1	Tablet, Film coatedOral	Chartwell RX, LLC	62135-085
Amoxicillin	Amoxicillin 500 mg/1	Tablet, Film coatedOral	Chartwell RX, LLC	62135-084
Amoxicillin	Amoxicillin 875 mg/1	Tablet, Film coatedOral	Teva Pharmaceuticals USA, Inc.	0093-2264